Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation

Jung W, Kim BH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatitis C virus-induced hepatocellular carcinoma

Goossens N, Hoshida Y

Hepatitis C virus (HCV) is a leading etiology of hepatocellular carcinoma (HCC). The interaction of HCV with its human host is complex and multilayered; stemming in part from the fact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?

Rou WS, Lee BS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI

Song KD, Jeong WK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report

Im SG, Yoo SH, Park YM, Lee SJ, Jang SK, Jeon DO, Cho HJ, Oh MJ

Lamotrigine is an anticonvulsant drug used to treat partial and generalized seizure disorders. Hypersensitivity to lamotrigine usually causes mild symptoms such as fever, rash, and slight invasion of internal organs....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Caroli's disease misdiagnosed as intraductal papillary neoplasm of the bile duct

Gu DH, Park MS, Jung CH, Yoo YJ, Cho JY, Lee YH, Seo YS, Yim HJ, Um SH, Ryu HS

Caroli's disease is a rare autosomal-recessive disorder caused by malformation of the ductal plate during embryonic development. Although it is present at birth, Caroli's disease is typically not diagnosed until...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Woo HY, Heo J

Despite advances in the treatment of hepatocellular carcinoma (HCC), managing HCC with portal vein thrombosis (PVT) remains challenging. PVT is present in 10-40% of HCC cases at the time of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO

BACKGROUND/AIMS: Therapies involving bone-marrow-derived mesenchymal stem cells (BM-MSCs) have considerable potential in the management of hepatic disease. BM-MSCs have been investigated in regenerative medicine due to their ability to secrete...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes

Park Y, Cho Y, Cho EJ, Kim YJ

BACKGROUND/AIMS: Overlap syndrome of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) (AIH-PBC overlap syndrome) is a rare disease that has not been clearly characterized in Korean patients. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients

Hwang JA, Kim KB, Yang MJ, Lim SG, Hwang JC, Cheong JY, Cho SW, Kim SS

BACKGROUND/AIMS: To determine the efficacies of entecavir (ETV) in nucleos(t)ide analogue (NA)-naive chronic hepatitis B (CHB) patients and in those with prior lamivudine (LAM) use who did not develop resistance. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Highly effective peginterferon alpha-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

Yang SY, Lee HW, Lee YJ, Park SJ, Yoo KY, Kim HJ

BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma

Park KH, Kwon SH, Lee YS, Jeong SW, Jang JY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ

BACKGROUND/AIMS: The predictive role of contrast-enhanced ultrasonography (CEUS) before performing transarterial chemoembolization (TACE) has not been determined. We assessed the possible predictive factors of CEUS for the response to TACE. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Cho YZ, Park SY, Choi EH, Baik SK, Kwon SO, Kim YJ, Cha SH, Kim MY

BACKGROUND/AIMS: The therapeutic effect of transarterial chemoembolization (TACE) against hepatocellular carcinoma (HCC) is usually assessed using multidetector computed tomography (MDCT). However, dense lipiodol depositions can mask the enhancement of viable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr